Please provide your email address to receive an email when new articles are posted on . FORT LAUDERDALE, Fla. — Best practices for safe subretinal delivery of gene therapy were presented at the Retina ...
Clinical Trials Arena on MSN
First patient treated in trial of Beacon Therapeutics’ XLRP treatment
Beacon Therapeutics has treated the first patient in its open-label LANDSCAPE trial of the potential gene therapy, laru-zova ...
Please provide your email address to receive an email when new articles are posted on . Injection in the subretinal space, currently performed or investigated for several cell-based and gene therapy ...
LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced that the first surgery using its proprietary Orbit™ Subretinal Delivery System ...
When the FDA approved Spark Therapeutics’ Luxturna in December 2017, gene therapy became a household concept. Chatter about gene therapy curing blindness became hot fodder at dinner tables and ...
A Moran lab and campus robotics colleagues are developing a new device with the potential to transform eye surgery. Spaces in the back of the eye below the retina measure just fractions of a ...
In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the ...
In experiments with rats, pigs and monkeys, researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the technique could provide a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback